EU
ORTX

Emory University’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Emory University’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,869
Closed -$1.29M – 14
2019
Q3 		$1.29M Sell
10,869
-1,471
-12% -$205K 2.55% 9
2019
Q2 		$1.73M Sell
12,340
-3,300
-21% -$579K 1.21% 40
2019
Q1 		$2.8M Buy
+15,640
New +$2.35M 1.97% 6

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Emory University's ORTX Position: Q4 2019 in Review

Emory University sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2019, closing a stake of 10,869 shares — an estimated $1.29M sold.

Emory University first reported a position in ORTX in Q1 2019 and held it in 3 quarters. The position peaked at $2.8M in Q1 2019. 81 funds tracked by Wall St. Rank hold ORTX as of Q4 2019.

  • Emory University reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
  • Emory University sold 10,869 Orchard Therapeutics plc American Depositary Shares shares in Q4 2019, an estimated $1.29M.
  • Emory University first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2019 and held it in 3 quarters.
  • Emory University's Orchard Therapeutics plc American Depositary Shares position peaked at $2.8M in Q1 2019.
  • 81 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2019.

Based on Emory University's 13F filing for Q4 2019, filed 13 Feb 2020.